| Title | Date | PubMed ID |
|---|
| DNA3'pp5'G de-capping activity of aprataxin: effect of cap nucleoside analogs and structural basis for guanosine recognition. | 2015 Jul 13 | 26007660 |
| Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. | 2014 Feb 6 | 24362567 |
| Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. | 2011 Oct 9 | 21984210 |
| Crystal structures of aprataxin ortholog Hnt3 reveal the mechanism for reversal of 5'-adenylated DNA. | 2011 Oct 9 | 21984208 |
| Genetic interactions between HNT3/Aprataxin and RAD27/FEN1 suggest parallel pathways for 5' end processing during base excision repair. | 2010 Jun 4 | 20399152 |
| CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response. | 2010 Mar | 20008512 |
| Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. | 2009 Nov 1 | 19643912 |
| The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. | 2006 Oct 12 | 16964241 |
| Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription. | 2006 Jul 15 | 16777843 |
| Aprataxin forms a discrete branch in the HIT (histidine triad) superfamily of proteins with both DNA/RNA binding and nucleotide hydrolase activities. | 2006 May 19 | 16547001 |